Tg Therapeutics Inc (TGTX)

Operating Cash Flow (Statement)

$39.26M

Quarterly · Period ending: · USD

TGTX logo

TGTX Operating Cash Flow (Statement)

Latest reported$39.26M
TGTX Quarterly Cash from Operations (-$1.00M → $39.26M)
High-resolution chart · PNG

TGTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-724,846
-2,377,782
1,508,573
-606,216
-1,631,765
-423,639
-200,000
-400,000
-900,000
-800,000
-1,200,000
-1,300,000
1,300,000
-1,400,000
-1,200,000
-1,100,000
-1,000,000
-800,000
-1,000,000
-1,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.